Laboratory Corporation of America Holdings subsidiaries

Path Lab Holdings, Inc. provides clinical laboratory testing services in the United States. The company caters to physician offices and nursing homes. The company was incorporated in 1993 and is based in Portsmouth, New Hampshire. Path Lab Holdings, Inc. operates as a subsidiary of Laboratory Corp. of America Holdings.

Dynacare Northwest, Inc. provides pathological diagnostic laboratory services. The company was incorporated in 1994 and is based in Seattle, Washington. Dynacare Northwest, Inc. operates as a subsidiary of Laboratory Corp. of America Holdings.

Personal Genome Diagnostics develops a patient-specific analysis of the cancer genome by using advanced tools and technologies. They were the first to sequence and analyze whole human cancer exomes and subsequently identified many alterations responsible for the development of cancer. They have described the principles underlying the genetic basis of human cancer and have developed novel technologies for non-invasive “liquid biopsy” approaches in cancer. Through PGDx, our founders bring their proprietary methods and expertise to research teams worldwide. The services help oncologists and translational scientists sequence and analyze cancer genomes and identify mutations to characterize aspects of the disease. Their expertise in genome analysis ranges from sample preparation and sequencing to data interpretation and analysis. They specialize in high-throughput next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes and have developed novel technologies for non-invasive “liquid biopsy” approaches in cancer. Personal Genome Diagnostics was founded in 2010 and is based in Baltimore, Maryland, United States.

Established in 1987, Cellmark has three decades‘ experience of providing police forces with high quality, specialist forensic science services.

We provide consulting and services to life science companies in Safety & Risk Management, Scientific Writing, Biometrics and Regulatory Affairs. Read on.

LipoScience is pioneering a new field of personalized diagnostics based on nuclear magnetic resonance (NMR) technology. Its first proprietary diagnostic test, the NMR LipoProfile test, measures the number of low density lipoprotein particles (LDL-P) in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease. To date, over 8 million NMR LipoProfile tests have been ordered.